Johnson & Johnson signals beyond the news: 44+ signals from 6 sources
The latest Johnson & Johnson signal on this page is from Sep 29, 2026 (Patents): "Janssen Biotech was granted a patent for manufacturing anti-IL-12/IL-23 antibodies." The busiest sources: Glassdoor (15+), LinkedIn (11) and Patents (10).
- Signals
- 44+
- Sources
- 6
- Last 90 days
- 31
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Johnson & Johnson signals by source
44+ signals for Johnson & Johnson across 6 sources.
Patents · Patent grant
Janssen Biotech was granted a patent for manufacturing anti-IL-12/IL-23 antibodies
In September 2026 Janssen Biotech patented methods for producing ustekinumab antibody compositions in CHO cells for pharmaceutical treatments across multiple diseases.
- Patent title
- Manufacturing methods for producing anti-IL12/IL23 antibody compositions
- Grant date
- Sep 29, 2026
- Inventors
- Kristopher Barnthouse, Subinay Ganguly, Maarten Groeneveld, Manuel Lopez, Jr.
Patents · Patent pace
Auris Health, Inc.'s patent output is slowing: 96 grants in the past year, 4 in the past 30 days.
Over the past year Auris Health, Inc. received 96 US patent grants, concentrated in image processing / graphics and artificial intelligence / machine learning; the recent pace (26 in 90 days) is slowing versus its trailing baseline.
- Grants, 12 months
- 96
- Grants, 90 days
- 26
- Grants, 30 days
- 4
- Pace
- Decelerating
Web traffic · Traffic snapshot
jnj.com received 3M monthly visits with traffic from 5 countries.
Minimal AI traffic at 0.7% (~18,287 visits). Top: chatgpt.com (79%), gemini.google.com (11%), claude.ai (6%).
- Monthly visits
- 2,627,626
- Month over month
- +1%
- 3-month change
- +9.6%
- Global rank
- 19,212
Glassdoor · Benefits praise
Employees praise strong benefits and good pay across multiple reviews
Three employees specifically mention good benefits and good pay, with one noting strong benefits and upward mobility when working hard and networking well.
- Overall rating
- 4.1 of 5
- CEO approval
- 85%
- Reviews read
- 10
- Review window
- Sep 4, 2026 to Sep 8, 2026
Glassdoor · Sales quota pressure
Workload can be challenging and approval times are long
Two employees note that workload can be challenging at times and that approval times are long, with one mentioning the need to walk the square to move things forward.
- Overall rating
- 4.1 of 5
- CEO approval
- 85%
- Reviews read
- 10
- Review window
- Sep 4, 2026 to Sep 8, 2026
Reddit · Customer feedback
Johnson & Johnson's upcoming Ottava surgical robot is viewed as an interesting platform similar to Intuitive's, but a sales role is considered potentially difficult as clinical trials have not yet...
Post: "Medtronic / JnJ / CMR"
- Subreddit
- r/MedicalDevices
- Upvotes
- 10
- Comments
- 10
- Sentiment
- Neutral
Reddit · Customer feedback
A commenter points out that Johnson & Johnson's drug Darzalex is a joint development with Genmab, clarifying the partnership behind the product.
Post: "World Best Selling Drugs"
- Subreddit
- r/biotech
- Upvotes
- 240
- Comments
- 61
- Sentiment
- Neutral
Podcasts · Platform strategy
Out of the Lab: Operationalizing Cell and Gene Therapy discusses Johnson & Johnson: platform strategy
"to control variability j and j opted a different route if they chose to do their own process tech transferred that to all the a3c sites okay and have that one process how they then cryopreserved the cells and then shifted towards their processing and manufacturing facilities"
- Podcast
- Out of the Lab: Operationalizing Cell and Gene Therapy
- Episode
- Designing for Resilience: Why CGT Supply Chain Begins Years Before Tech Transfer | Mehran Bhatti
- Speaker
- Mehran Bhatti
- Speaker role
- Third party
Web traffic · Sustained growth
jnj.com shows sustained growth with 3 consecutive months of increases, up 14% overall to 3M.
Minimal AI traffic at 0.7% (~19,047 visits). Top: chatgpt.com (89%), gemini.google.com (7%), perplexity.ai (2%), copilot.microsoft.com (0%).
- Monthly visits
- 2,601,113
- Month over month
- +8.5%
- 3-month change
- +13.8%
- Global rank
- 19,444
LinkedIn
At J&J in EMEA, we’re committed to creating opportunities for all candidates to thrive and make an impact.
At J&J in EMEA, we’re committed to creating opportunities for all candidates to thrive and make an impact. We’ve shared three surprising facts - now it’s your turn! What other fun facts do you know about J&J? Let us know in the comments! From our Credo carved in stone to a global presence that never sleeps, these...
- Likes
- 99
- Tags
- Recruitment, Company Culture & Policy, Employee Engagement
Showing 10 of 44+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Johnson & Johnson with the Signal API
One POST /v1/companies/enrich call with jnj.com returns Johnson & Johnson signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "jnj.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Johnson & Johnson other signals
What signals does Autobound track for Johnson & Johnson besides news and filings?
What are people saying about Johnson & Johnson online?
What do employees say about working at Johnson & Johnson?
Has Johnson & Johnson been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .